Marlow Industries Wins Contract to Develop New Thermoelectric Materials

Marlow Industries today announced the award of a $3.9 million contract by the Defense Advanced Research Projects Agency (DARPA) for the development of new thermoelectric materials and active cooling modules.

The advancements in thermoelectric materials and devices will enable Department of Defense (DOD) thermal management systems to operate at lower temperatures with higher performance and longer lifetime.

The materials in development by Marlow Industries will extend the present state of the art by utilizing a unique Colloidal Nanocrystal (ICN) synthesis to produce high performance nanocomposite thermoelectric materials. When combined with Marlow Industries' leading thermoelectric modeling and device assembly capabilities, the advancement will revolutionize thermoelectric cooling and impact a vast array of commercial and military applications.

The Active Cooling Module program will extend over 24 months culminating in a design to meet or exceed the DARPA program goals. Follow-on contracts are anticipated to apply this technology to specific military applications. Marlow Industries will lead an accomplished team of academic and commercial partners to fulfill the program goals, including: Evident Technologies (Troy NY), the University of Texas at Dallas, and the University of Colorado at Boulder.

"The impact of this program will result in significant advances for thermoelectric material design and device construction that will disrupt the current industry standard and enable improvements across the board," said Barry Nickerson, Marlow Industries general manager. "We are pleased to work with DARPA and our partners on this landmark achievement in thermal management technology."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.